No Data
No Data
Special treat Ningke's semi-annual report for 2024.
Summary of ST NINGKE's 2024 interim report.
ST Ningke (600165.SH) released its first-half performance, with a net loss of 0.425 billion yuan.
ST NINGKE (600165.SH) released its 2024 interim report, and the company achieved revenue during the reporting period...
*Special treat Ningke's performance is expected to be a loss in the first half of 2024.
Why We're Not Concerned Yet About Ningxia Zhongke Biotechnology Co., Ltd's (SHSE:600165) 27% Share Price Plunge
*ST Ningke (600165.SH): The overall debt scale is 2.63 billion yuan, severely lacking in debt repayment funds and liquidity assets.
*ST Ningke (600165.SH) announced that the company's stock hit the limit down on June 13, 2024, trading volume of 2 million shares, accounting for 0.05% of total share capital. Trading will resume on June 14, 2024.
No Data